Clinical study to assess the efficacy and safety of TA-650 in patients with active ulcerative colitis
Latest Information Update: 25 May 2016
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 24 May 2016 New trial record